Advanced search
Publication Cover
International Journal of Neuroscience Volume 118, 2008 - Issue 5
Submit an article Journal homepage
304
Views
29
CrossRef citations to date
0
Altmetric
Original

The Effects of Antidepressants in Parkinson’s Disease: A Meta-Analysis

Pasquale G. Frisina Leir Parkinson's Disease Program, The Jewish Home and Hospital Lifecare System, New York, New York, USA; Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, New York, USA
,
Harriet R. Tenenbaum Department of Psychology, Kingston University, Kingston upon Thames, United Kingdom
,
Joan C. Borod Department of Psychology, Queens College and The Graduate Center of the City, University of New York, Flushing, New York, USA; Department of Neurology, Mount Sinai School of Medicine, New York, New York, USA
&
Nancy S. Foldi Department of Psychology, Queens College and The Graduate Center of the City, University of New York, Flushing, New York, USA; Division of Geriatrics, Department of Medicine, Winthrop-University Hospital SUNY Stony Brook School of Medicine, Stony Brook, New York, USA
Pages 667-682 | Received 30 Oct 2006, Published online: 07 Jul 2009

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Khalid Orayj. (2021) Impact of Antidepressants on Cardiac Events and All-Cause Mortality in Parkinson’s Disease: A National Data-Linkage Study. Neuropsychiatric Disease and Treatment 17, pages 2499-2510.
Read now
Jenny Kim, Ellen Sidransky & Grisel Lopez. (2015) Understanding and managing parkinsonism in patients with glucocerebrosidase mutations. Expert Opinion on Orphan Drugs 3:5, pages 549-562.
Read now
Chi-Un Pae. (2013) Use of antidepressants for depression in patients with Parkinson's disease. Expert Opinion on Pharmacotherapy 14:3, pages 255-257.
Read now

Articles from other publishers (26)

Mir Hilal Ahmad, Moshahid Alam Rizvi, Mansoor Ali & Amal Chandra Mondal. (2023) Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies. Ageing Research Reviews 85, pages 101840.
Crossref
Xiao-Le Wang, Si-Tong Feng, Ya-Ting Wang, Bin Chen, Zhen-Zhen Wang, Nai-Hong Chen & Yi Zhang. (2022) Comparative efficacy and acceptability of drug treatments for Parkinson’s disease with depression: A systematic review with network meta-analysis. European Journal of Pharmacology 927, pages 175070.
Crossref
Si-Tong Feng, Xiao-Le Wang, Ya-Ting Wang, Yu-He Yuan, Zhi-Peng Li, Nai-Hong Chen, Zhen-Zhen Wang & Yi Zhang. (2021) Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson’s Disease with Depression: A Systematic Review and Meta-Analysis. The American Journal of Chinese Medicine 49:03, pages 627-643.
Crossref
A. G. Kashezhev, M. V. Sinkin & N. A. Skripkina. (2019) Use of Transcranial Magnetic Stimulation in the Correction of Affective Disorders in Parkinson’s Disease. Neuroscience and Behavioral Physiology 49:4, pages 441-443.
Crossref
Timothy J. Collier, Kinshuk R. Srivastava, Craig Justman, Tom Grammatopoulous, Birgit Hutter-Paier, Manuela Prokesch, Daniel Havas, Jean-Christophe Rochet, Fang Liu, Kevin Jock, Patrícia de Oliveira, Georgia L. Stirtz, Ulf Dettmer, Caryl E. Sortwell, Mel B. Feany, Peter Lansbury, Lisa Lapidus & Katrina L. Paumier. (2017) Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiology of Disease 106, pages 191-204.
Crossref
Chuanjun Zhuo, Rong Xue, Lanlan Luo, Feng Ji, Hongjun Tian, Hongru Qu, Xiaodong Lin, Ronghuan Jiang & Ran Tao. (2017) Efficacy of antidepressive medication for depression in Parkinson disease. Medicine 96:22, pages e6698.
Crossref
A. G. Kashezhev, M. V. Sinkin & N. A. Skripkina. (2017) The use of transcranial magnetic stimulation in treatment of affective disorders in Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:6, pages 66.
Crossref
Hans-Peter Kapfhammer. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 2693 2805 .
Roy G Elbers, John Verhoef, Erwin EH van Wegen, Henk W Berendse & Gert Kwakkel. (2015) Interventions for fatigue in Parkinson's disease. Cochrane Database of Systematic Reviews 2015:10.
Crossref
Agnieszka Dyduch & Maria Za?uska. (2015) Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review. Psychogeriatrics 15:2, pages 147-153.
Crossref
Katrina L Paumier, Caryl E Sortwell, Lalitha Madhavan, Brian Terpstra, Stephanie L Celano, Joshua J Green, Nastassja M Imus, Nathan Marckini, Brian Daley, Kathy Steece-Collier & Timothy J Collier. (2014) Chronic Amitriptyline Treatment Attenuates Nigrostriatal Degeneration and Significantly Alters Trophic Support in a Rat Model of Parkinsonism. Neuropsychopharmacology 40:4, pages 874-883.
Crossref
Kentaro Hirao, Gregory M. Pontone & Gwenn S. Smith. (2015) Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease. Neuroscience & Biobehavioral Reviews 49, pages 157-170.
Crossref
H.-P. Kapfhammer. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1 114 .
Paul J. Fitzgerald. (2014) Is elevated norepinephrine an etiological factor in some cases of Parkinson’s disease?. Medical Hypotheses 82:4, pages 462-469.
Crossref
Lakkhina Troeung, Sarah J. Egan & Natalie Gasson. (2013) A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s Disease. PLoS ONE 8:11, pages e79510.
Crossref
Julian Hellmann-Regen, Dominique Piber, Kim Hinkelmann, Stefan M. Gold, Christoph Heesen, Carsten Spitzer, Matthias Endres & Christian Otte. (2013) Depressive syndromes in neurological disorders. European Archives of Psychiatry and Clinical Neuroscience 263:S2, pages 123-136.
Crossref
U. Spampinato & F. Tison. (2013) Depressione e malattia di Parkinson. EMC - Neurologia 13:1, pages 1-15.
Crossref
U. Spampinato & F. Tison. (2012) Dépression et maladie de Parkinson. EMC - Neurologie 9:4, pages 1-15.
Crossref
Katrina L. Paumier, Andrew D. Siderowf, Peggy Auinger, David Oakes, Lalitha Madhavan, Alberto J. Espay, Fredy J. Revilla & Timothy J. Collier. (2012) Tricyclic antidepressants delay the need for dopaminergic therapy in early Parkinson's disease. Movement Disorders 27:7, pages 880-887.
Crossref
Darcy Litteljohn & Shawn Hayley. 2012. Psychoneuroimmunology. Psychoneuroimmunology 121 144 .
Kimberly Pargeon, Karen Anderson & William J. Weiner. 2011. Parkinson's Disease. Parkinson's Disease 296 303 .
H.-P. Kapfhammer. 2011. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 2511 2598 .
Petros Skapinakis, Eleni Bakola, Georgia Salanti, Glyn Lewis, Athanasios P Kyritsis & Venetsanos Mavreas. (2010) Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurology 10:1.
Crossref
Darcy Litteljohn, Emily Mangano & Shawn Hayley. 2010. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. Brain Protection in Schizophrenia, Mood and Cognitive Disorders 185 241 .
Dag Aarsland, Laura Marsh & Anette Schrag. (2009) Neuropsychiatric symptoms in Parkinson's disease. Movement Disorders 24:15, pages 2175-2186.
Crossref
Clive Ballard, Anne Corbett, Ramilgan Chitramohan & Das Aarsland. (2009) Management of agitation and aggression associated with Alzheimerʼs disease: controversies and possible solutions. Current Opinion in Psychiatry 22:6, pages 532-540.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.